NEW YORK, Dec. 3, 2018 /PRNewswire/ -- Scott+Scott Attorneys at Law LLP ("Scott+Scott"), a national shareholder and consumer rights litigation firm, is investigating whether Aphria, Inc. ("Aphria" or the "Company") (NYSE: APHA) or certain of its officers and directors violated federal securities laws. If you purchased Aphria stock on the New York Stock Exchange ("NYSE"), you are encouraged to contact a Scott+Scott attorney at (844) 818-6982 for more information.
Aphria is a Canadian company that produces, supplies, and sells medical marijuana.
On December 3, 2018, Hindenburg Research released a report titled, "Aphria: A Shell Game with a Cannabis Business on the Side." According to the report, which was also released on Seeking Alpha, "Aphria is part of a scheme orchestrated by a network of insiders to divert funds away from shareholders into their own pockets."
On this news, the price of Aphria stock is currently down $2.17 – over 27% – in intraday trading on the NYSE.
What You Can Do
If you purchased Aphria stock on the NYSE, and you wish to discuss this investigation, please contact attorney Joe Pettigrew at (844) 818-6982, or at email@example.com, or visit the Aphria investigation page on our website at https://scott-scott.com/investigation/aphria-inc.
About Scott+Scott Attorneys at Law LLP
Scott+Scott has significant experience in prosecuting major securities, antitrust, and employee retirement plan actions throughout the United States. The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Connecticut, California, and Ohio.
SOURCE Scott+Scott Attorneys at Law LLP